Atlas Trials

Ketamine Challenge Study With JNJ-40411813

Clinical trial NCT01101659 · COMPLETED

Trial details

NCT number
NCT01101659
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Perceptual DisordersConfusionSchizophrenia
Start date
2010-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.